FDA warns antipsychotic drugs may be risky for elderly

JAMA. 2005 May 25;293(20):2462. doi: 10.1001/jama.293.20.2462.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Benzodiazepines / adverse effects
  • Clozapine / adverse effects
  • Dementia / drug therapy*
  • Dibenzothiazepines / adverse effects
  • Drug Approval
  • Drug Labeling
  • Humans
  • Olanzapine
  • Piperazines / adverse effects
  • Quetiapine Fumarate
  • Quinolones / adverse effects
  • Risperidone / adverse effects
  • Thiazoles / adverse effects
  • United States
  • United States Food and Drug Administration*

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Quinolones
  • Thiazoles
  • Benzodiazepines
  • Quetiapine Fumarate
  • ziprasidone
  • Aripiprazole
  • Clozapine
  • Risperidone
  • Olanzapine